ZA925581B - Pharmaceutical microemulsions. - Google Patents

Pharmaceutical microemulsions.

Info

Publication number
ZA925581B
ZA925581B ZA925581A ZA925581A ZA925581B ZA 925581 B ZA925581 B ZA 925581B ZA 925581 A ZA925581 A ZA 925581A ZA 925581 A ZA925581 A ZA 925581A ZA 925581 B ZA925581 B ZA 925581B
Authority
ZA
South Africa
Prior art keywords
microemulsions
hlb surfactant
pharmaceutical
emulsifying
iii
Prior art date
Application number
ZA925581A
Other languages
English (en)
Inventor
Panayiuotis Per Constantinides
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24959558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA925581(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA925581B publication Critical patent/ZA925581B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA925581A 1991-07-26 1992-07-24 Pharmaceutical microemulsions. ZA925581B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73635491A 1991-07-26 1991-07-26

Publications (1)

Publication Number Publication Date
ZA925581B true ZA925581B (en) 1993-05-14

Family

ID=24959558

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925581A ZA925581B (en) 1991-07-26 1992-07-24 Pharmaceutical microemulsions.

Country Status (15)

Country Link
EP (1) EP0597007B1 (el)
JP (1) JPH06509796A (el)
AT (1) ATE144137T1 (el)
AU (1) AU667316B2 (el)
CA (1) CA2114141A1 (el)
DE (1) DE69214652T2 (el)
DK (1) DK0597007T3 (el)
ES (1) ES2093269T3 (el)
GR (1) GR3022260T3 (el)
IL (1) IL102633A0 (el)
MX (1) MX9204379A (el)
NZ (1) NZ243703A (el)
PT (1) PT100726A (el)
WO (1) WO1993002664A1 (el)
ZA (1) ZA925581B (el)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
NZ243721A (en) * 1991-07-26 1994-11-25 Smithkline Beecham Corp Self-emulsifying microemulsion comprising water soluble drug, high hlb surfactant and a lipophilic phase containing fatty acid triglyceride and a low hlb surfactant
EP0746331B1 (en) * 1992-10-16 2000-09-13 IBAH, Inc. Convertible microemulsion formulations
EP0666752A4 (en) * 1992-10-16 1996-09-11 Smithkline Beecham Corp THERAPEUTIC MICROEMULSIONS.
WO1994008603A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Compositions
EP0684834A4 (en) * 1993-02-17 1996-09-25 Smithkline Beecham Corp MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES.
US5948825A (en) * 1993-04-19 1999-09-07 Institute For Advanced Skin Research Inc. Microemulsion preparation containing a slightly absorbable substance
EP0721380B1 (en) * 1993-09-29 1999-05-26 Technobiochip Protein thin films and compositions for use in their preparation
US5707648A (en) * 1993-11-17 1998-01-13 Lds Technologies, Inc. Transparent liquid for encapsulated drug delivery
CA2185803C (en) * 1994-03-18 2006-07-11 Edward M. Rudnic Emulsified drug delivery systems
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
SE9503143D0 (sv) 1995-09-12 1995-09-12 Astra Ab New preparation
GB9613858D0 (en) * 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
TWI241915B (en) 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
CN1329502A (zh) * 1998-12-04 2002-01-02 普罗瓦利斯英国有限公司 含有胰岛素的药物组合物
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
DE60231549D1 (de) * 2001-12-03 2009-04-23 Dor Biopharma Inc Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
AU2002231703B2 (en) 2001-12-14 2007-03-29 Jagotec Ag Pharmaceutical formulation comprising cyclosporin and use thereof
US20050232974A1 (en) * 2004-04-19 2005-10-20 Gore Makarand P System and a method for pharmaceutical dosage preparation using jettable microemulsions
CN105801686B (zh) 2004-07-19 2020-04-07 比奥孔有限公司 胰岛素-低聚物共轭物、制剂及其用途
RU2429850C2 (ru) 2005-04-15 2011-09-27 Кларус Терапьютикс, Инк. Фармацевтические системы доставки для гидрофобных лекарственных средств и композиций, их содержащих
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
ITMI20060618A1 (it) * 2006-03-31 2007-10-01 Enitecnologie Spa Procedimento per la preparazione di nanoemulsioni acqua ion olio e olio in acqua
EP1961412A1 (en) 2006-12-27 2008-08-27 LEK Pharmaceuticals D.D. Self-microemulsifying drug delivery systems
EP2164466A1 (en) * 2007-06-01 2010-03-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
WO2009041105A1 (ja) * 2007-09-27 2009-04-02 Riken Vitamin Co., Ltd. ソフトカプセル充填用液状組成物
JP5156458B2 (ja) * 2008-03-31 2013-03-06 理研ビタミン株式会社 ソフトカプセル充填用液状組成物
EP2203181B1 (en) 2007-10-16 2018-02-14 Biocon Limited An orally administerable solid pharmaceutical composition and a process thereof
JP5749155B2 (ja) 2008-03-18 2015-07-15 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化アシル化インスリンアナログ
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011004395A1 (en) * 2009-07-06 2011-01-13 Intas Biopharmaceuticals Limited Microemulsion formulation for biologicals
WO2011076207A2 (en) * 2009-12-22 2011-06-30 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
US20120058187A1 (en) * 2010-09-03 2012-03-08 Novagali Pharma Sa Water-in-oil type emulsion for treating a disease of the eye
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
GB201107630D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Microemulsions
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
MX2014012096A (es) 2012-04-11 2014-11-21 Novo Nordisk As Formulaciones de insulina.
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080994A (en) * 1963-10-25 1967-08-31 Nat Res Dev Injectable emulsions containing antigens
US4840660A (en) * 1985-12-30 1989-06-20 Rhone Poulenc Nederlands B.V. Plant growth regulator dispersions
IE60024B1 (en) * 1987-02-03 1994-05-18 Stiefel Laboratories Ltd Microemulsions
NZ243721A (en) * 1991-07-26 1994-11-25 Smithkline Beecham Corp Self-emulsifying microemulsion comprising water soluble drug, high hlb surfactant and a lipophilic phase containing fatty acid triglyceride and a low hlb surfactant

Also Published As

Publication number Publication date
AU2411592A (en) 1993-03-02
IL102633A0 (en) 1993-01-14
EP0597007A1 (en) 1994-05-18
EP0597007B1 (en) 1996-10-16
WO1993002664A1 (en) 1993-02-18
GR3022260T3 (en) 1997-04-30
DE69214652T2 (de) 1997-03-20
CA2114141A1 (en) 1993-02-18
MX9204379A (es) 1993-02-01
JPH06509796A (ja) 1994-11-02
PT100726A (pt) 1993-09-30
ES2093269T3 (es) 1996-12-16
ATE144137T1 (de) 1996-11-15
NZ243703A (en) 1995-12-21
DE69214652D1 (de) 1996-11-21
AU667316B2 (en) 1996-03-21
DK0597007T3 (da) 1996-11-18

Similar Documents

Publication Publication Date Title
ZA925581B (en) Pharmaceutical microemulsions.
ZA925580B (en) Pharmaceutical miroemulsions.
DE69403057D1 (de) Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet
KR100666016B1 (ko) 테스토스테론 운데카노에이트 및 피마자유를 포함하는 제제
ZA966067B (en) New pharmaceutical dosage formulations of fenofibrate and their applications
AP2000001943A0 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
PT918507E (pt) Formulacoes em aerossol
ES2186715T3 (es) Uso de un tensioactivo lipofilico en una composicion farmaceutica.
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
DE69332078D1 (de) Arzneimittel enthaltende cyclosporinderivate
EP0766960A4 (en) PREPARATIONS FOR EXTERNAL USE FOR THE TREATMENT OF DERMATOS
CA2362277A1 (en) Spontaneously dispersible n-benzoyl staurosporine compositions
CA2326198A1 (en) Cosolvent formulations
WO2001064187A8 (en) Anaesthetic formulations
NZ313899A (en) Oral cyclosporin compositions comprising cyclosporin A, a solvent either ethanol or propylene glycol and one non-ionic polyoxyethylene surfactant selected from polyoxyethylene alcohols and mono-esters of ethoxylated sorbitans
IT1317871B1 (it) Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche.
MX9604004A (es) Formualciones de farmaco en aerosol que contienen vitamina e.
HUP0002118A2 (hu) Fiziológiai közegben rosszul oldódó peptideket tartalmazó gyógyszerkészítmények
CO4340678A1 (es) Formulaciones para agentes farmaceuticos administrados en forma oral